Health : Medical Research

LuMind Research Down Syndrome Foundation

Research Down Syndrome

three stars

85.38

225 Cedar Hill Street Suite 200
Marlborough, MA 01752
tel: (508) 630-2177   Web Site
EIN: 37-1483975

Board Leadership
Ryan M. Hartman
Chair

CEO
Hampus Hillerstrom
President, CEO

  Score
(out of 100)
Rating
Overall Score & Rating 85.38 three stars
  Financial 82.50 three stars
  Accountability & Transparency 89.00 three stars
This rating was published 03/01/2019 and includes data from FY2017, the most recent 990 received at that time.

The mission of the LuMind Research Down Syndrome Foundation is to stimulate biomedical research that will accelerate the development of treatments to significantly improve cognition, including memory, learning and speech, for individuals with Down syndrome. This will allow individuals with Down syndrome to participate more successfully in school, lead to more active and independent lives, as well as avoid the early onset Alzheimer's Disease. LuMind only supports research that focuses on understanding and improving cognition. Moreover, LuMind only supports researchers and institutions that are committed to seeing their basic research translated into effective treatments. In order to increase the likelihood of a breakthrough in the treatment of Down syndrome, LuMind supports multi-disciplinary research, and encourages frequent collaboration among scientists in different fields and at different research institutions.

The mission of the LuMind Research Down Syndrome Foundation is to stimulate biomedical research that will accelerate the development of treatments to significantly improve cognition, including memory, learning and speech, for individuals with Down syndrome. This will allow individuals with Down syndrome to participate more successfully in school, lead to more active and independent lives, as well as avoid the early onset Alzheimer's Disease. LuMind only supports research that focuses on understanding and improving cognition. Moreover, LuMind only supports researchers and institutions that are committed to seeing their basic research translated into effective treatments. In order to increase the likelihood of a breakthrough in the treatment of Down syndrome, LuMind supports multi-disciplinary research, and encourages frequent collaboration among scientists in different fields and at different research institutions.

Impact Information

data icon Looking for Impact Information?

Charity Navigator is collaborating with GuideStar, GlobalGiving, Classy, and ImpactMatters to display impact-related information on our rated profile pages. Each partner collects this data directly from nonprofits and provides updates to Charity Navigator when available.

If you are interested in seeing this charity provide its impact information, please click below. This will indicate your interest and encourage the nonprofit to share data with partners that are currently collecting information.

Financial

three stars

82.50

Accountability & Transparency

three stars

89.00

This rating was published 03/01/2019 and includes data from FY2017, the most recent 990 received at that time.
Overall Rating Chart
  Program Expenses
(Percent of the charity's total expenses spent on the programs
and services it delivers)
86.4%
  Administrative Expenses 3.9%
  Fundraising Expenses 9.5%
  Fundraising Efficiency $0.15
  Working Capital Ratio (years) 0.07
  Program Expenses Growth 9.1%
  Liabilities to Assets 91.2%
All data for Financial Performance Metrics calculations was provided by LuMind Research Down Syndrome Foundation on recent 990s filed with the IRS.
All data for Financial Performance Metrics calculations was provided by LuMind Research Down Syndrome Foundation on recent 990s filed with the IRS.
REVENUE  
Contributions  
   Contributions, Gifts & Grants $0
   Federated Campaigns $1,698,058
   Membership Dues $0
   Fundraising Events $0
   Related Organizations $0
   Government Grants $0
Total Contributions $1,698,058
   Program Service Revenue $0
Total Primary Revenue $1,698,058
   Other Revenue $540,573
TOTAL REVENUE $2,238,631
   
EXPENSES  
   Program Expenses $2,340,199
   Administrative Expenses $163,630
   Fundraising Expenses $317,970
TOTAL FUNCTIONAL EXPENSES $2,821,799
   
Payments to Affiliates $0
Excess (or Deficit) for the year $-583,168
   
Net Assets $193,740

Charts

Compensation % of Expenses Paid to Title
Not compensated -- Hampus Hillerstrom President, CEO
Other Salaries of Note
$185,452 6.57% Michael M. Harpold Chief Scientific Officer
$130,789 4.63% Carolyn Cronin Former Executive Director

Mission

The mission of the LuMind Research Down Syndrome Foundation is to stimulate biomedical research that will accelerate the development of treatments to significantly improve cognition, including memory, learning and speech, for individuals with Down syndrome. This will allow individuals with Down syndrome to participate more successfully in school, lead to more active and independent lives, as well as avoid the early onset Alzheimer's Disease. LuMind only supports research that focuses on understanding and improving cognition. Moreover, LuMind only supports researchers and institutions that are committed to seeing their basic research translated into effective treatments. In order to increase the likelihood of a breakthrough in the treatment of Down syndrome, LuMind supports multi-disciplinary research, and encourages frequent collaboration among scientists in different fields and at different research institutions.

Highly Rated

Charity Name & State Overall Score Overall Rating
LuMind Research Down Syndrome Foundation (MA) 85.38 three stars
Foundation for the National Institutes of Health (MD) 96.20 four stars
Oklahoma Medical Research Foundation (OK) 98.11 four stars
Salk Institute for Biological Studies (CA) 92.82 four stars
International AIDS Vaccine Initiative (NY) 91.12 four stars

Compare These Charities (Highly Rated)

Charity Contact Info

LuMind Research Down Syndrome Foundation
225 Cedar Hill Street
Suite 200
Marlborough, MA 01752
tel: (508) 630-2177
fax: (508) 630-2101
EIN: 37-1483975

Visit Web Site

Board Leadership

Ryan M. Hartman
Chair

CEO

Hampus Hillerstrom
President, CEO